| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Radiation Oncology, The University of Arizona Health Sciences Center, Tucson, Arizona 85724 [M. B., W. C., H. L. G., G. T. B.], and The Hormel Institute, University of Minnesota, Austin, Minnesota 55912 [C. H., Z. D.]
The monoterpene perillyl alcohol (POH) has proven efficacious against the formation and progression of a variety of cancers. In this study, we tested the ability of POH to inhibit photocarcinogenesis in a nonmelanoma model of mouse skin carcinogenesis and its ability to inhibit UVB-induced activator protein 1 (AP-1) transactivation in mouse skin and human keratinocytes. POH (10 mM) was applied topically to the ears and shaved dorsal surface of groups of 35 BALB/c mice throughout the experiment, during and after UVB treatment. Topical POH significantly inhibited tumor incidence and multiplicity, average tumor size, and the average tumor burden/mouse without any apparent toxicity. POH inhibited UVB-induced AP-1 transactivation in both cultured human keratinocytes and transgenic mice that stably express a luciferase reporter driven by AP-1 elements. The results suggest that POH might be used for chemoprevention of human skin cancer, and that inhibition of AP-1 activity is functionally related to inhibition of skin carcinogenesis.
1 Supported by NIH Grant CA-27502.
2 To whom requests for reprints should be addressed, at Department of Radiation Oncology, The University of Arizona Health Sciences Center, 1515 North Campbell Avenue, Tucson, AZ 85724. Phone: (520) 626-6006; Fax: (520) 626-4480.
Received 9/12/97. Accepted 12/16/97.
This article has been cited by other articles:
![]() |
A. Charruyer, S. Grazide, C. Bezombes, S. Muller, G. Laurent, and J.-P. Jaffrezou UV-C Light Induces Raft-associated Acid Sphingomyelinase and JNK Activation and Translocation Independently on a Nuclear Signal J. Biol. Chem., May 13, 2005; 280(19): 19196 - 19204. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Bachelor, S. J. Cooper, E. T. Sikorski, and G. T. Bowden Inhibition of p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase Decreases UVB-Induced Activator Protein-1 and Cyclooxygenase-2 in a SKH-1 Hairless Mouse Model Mol. Cancer Res., February 1, 2005; 3(2): 90 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-K. Won, C.-N. Ong, X. Shi, and H.-M. Shen Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms Carcinogenesis, August 1, 2004; 25(8): 1449 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Clark, L. Zhong, D. Filiault, S. Perman, Z. Ren, M. Gould, and X. Yang Anti-Leukemia Effect of Perillyl Alcohol in Bcr/Abl-Transformed Cells Indirectly Inhibits Signaling through Mek in a Ras- and Raf-Independent Fashion Clin. Cancer Res., October 1, 2003; 9(12): 4494 - 4504. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Liston, R. Nines, P. S. Carlton, A. Gupta, R. Aziz, W. Frankel, and G. D. Stoner Perillyl Alcohol as a Chemopreventive Agent in N-Nitrosomethylbenzylamine-induced Rat Esophageal Tumorigenesis Cancer Res., May 15, 2003; 63(10): 2399 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-F. Demierre and L. Nathanson Chemoprevention of Melanoma: An Unexplored Strategy J. Clin. Oncol., January 1, 2003; 21(1): 158 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lluria-Prevatt, J. Morreale, J. Gregus, D. S. Alberts, F. Kaper, A. Giaccia, and M. B. Powell Effects of Perillyl Alcohol on Melanoma in the TPras Mouse Model Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 573 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, A. Bode, W.-Y. Ma, S. Sang, C.-T. Ho, and Z. Dong Two Novel Glycosides from the Fruits of Morinda Citrifolia (Noni) Inhibit AP-1 Transactivation and Cell Transformation in the Mouse Epidermal JB6 Cell Line Cancer Res., August 1, 2001; 61(15): 5749 - 5756. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chen, M. Nomura, Q.-B. She, W.-Y. Ma, A. M. Bode, L. Wang, R. A. Flavell, and Z. Dong Suppression of Skin Tumorigenesis in c-Jun NH2-Terminal Kinase-2-Deficient Mice Cancer Res., May 1, 2001; 61(10): 3908 - 3912. [Abstract] [Full Text] |
||||
![]() |
S. Zhong, J. A. Quealy, A. M. Bode, M. Nomura, A. Kaji, W.-Y. Ma, and Z. Dong Organ-specific Activation of Activator Protien-1 in Transgenic Mice by 12-O-Tetradecanoylphorbol-13-acetate with Different Administration Methods Cancer Res., May 1, 2001; 61(10): 4084 - 4091. [Abstract] [Full Text] |
||||
![]() |
A. Gupta, S. F. Rosenberger, and G. T. Bowden Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines Carcinogenesis, November 1, 1999; 20(11): 2063 - 2073. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kramer-Stickland, A. Edmonds, W. B. Bair III, and G.T. Bowden Inhibitory effects of deferoxamine on UVB-induced AP-1 transactivation Carcinogenesis, November 1, 1999; 20(11): 2137 - 2142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ding, X. Shi, Z. Dong, F. Chen, Y. Lu, V. Castranova, and V. Vallyathan Freshly Fractured Crystalline Silica Induces Activator Protein-1 Activation through ERKs and p38 MAPK J. Biol. Chem., October 22, 1999; 274(43): 30611 - 30616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ding, Z. Dong, F. Chen, D. Pack, W.-Y. Ma, J. Ye, X. Shi, V. Castranova, and V. Vallyathan Asbestos Induces Activator Protein-1 Transactivation in Transgenic Mice Cancer Res., April 1, 1999; 59(8): 1884 - 1889. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, A. H. Borchers, Z. Dong, M. B. Powell, and G. T. Bowden UVB Irradiation-induced Activator Protein-1 Activation Correlates with Increased c-fos Gene Expression in a Human Keratinocyte Cell Line J. Biol. Chem., November 27, 1998; 273(48): 32176 - 32181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ding, X. Shi, Y. Lu, C. Huang, S. Leonard, J. Roberts, J. Antonini, V. Castranova, and V. Vallyathan Induction of Activator Protein-1 through Reactive Oxygen Species by Crystalline Silica in JB6 Cells J. Biol. Chem., March 16, 2001; 276(12): 9108 - 9114. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |